Investor Relations

ALADDIN HEALTHCARE TECHNOLOGIES SE

REGISTERED CAPITAL: EUR 11,458,238
NUMBER OF SHARES: 11,458,238 no par bearer shares
STOCK EXCHANGE: Dusseldorf (Regulated market), Xetra, Frankfurt, Berlin, Munich
WKN: A12ULL
ISIN: DE000A12ULL2
TICKER SYMBOL: NMI

PRESS ARTICLES

Management Interviews (Nebenwerte Magazin)

Aladdin Healthcare Technologies – combining science and AI for breakthroughs in age-related disease (The Innovation Platform)

AD-HOC REPORTING

Ad-hoc News from 18.05.2021
Ad-hoc News from 08.12.2020
Ad-hoc News from 06.04.2020
Ad-hoc News from 03.03.2020
Ad-hoc News from 30.04.2019
Ad-hoc News from 09.10.2018
Ad-hoc News from 21.09.2018
Ad-hoc News from 19.09.2018
Ad-hoc News from 13.06.2018
Ad-hoc News from 12.06.2018
Ad-hoc News from 07.03.2018
Ad-hoc News from 06.03.2018
Ad-hoc News from 06.12.2017
Ad-hoc News from 05.12.2017
Ad-hoc News from 06.11.2017

SHAREHOLDER MEETINGS

Invitation to the Annual General Meeting 2021
Authority Form 2021
Proxy Form 2021
Revocation Form 2021
Table 3 2021
Information on Shareholder's Rights 2021
Report of the Board of Directors for 2019
Report of the Board of Directors for 2018
Results of the votes Aladdin AGM 2018
Invitation to the Annual General Meeting 2018
Board of Directors Report 2018
Privacy notice 2018
Explanation of the shareholders’ rights 2018
Authority Form 2018
Proxy Form 2018
Revocation Form 2018
Reports of the Board of Directors for FY 2017
Agenda of the Extraordinary General Meeting on March 7th, 2018
Invitation to the ordinary AGM 2017
Reports of the Board of Directors for FY 2015 & 2016

FINANCIAL STATEMENTS

Half-Year Financial Report 2021
Annual Report of the Group 2020
Annual Financial Statements 2020 (German)
Half-Year Financial Report 2020
Annual Report of the Group 2019
Annual Financial Statements 2019 (German)
Semi-Annual Report of the Group as of 30.06.2019
Annual Report of the Group 2018
Annual Report 2018
Semi-Annual Report as of 30.06.2018
Annual Financial Statements 2017 (German)
Annual Financial Statements 2017

FINANCIAL CALENDAR

Full Year Report: June 2022
Annual General Meeting: October 2022
Half-Year Report: September 2022

CORPORATE GOVERNANCE

Corporate Governance Declarations

Directors’ Dealings

Wade Menpes-Smith (Chairman)
Conversion of a loan amount into shares and transfer of these shares to the lender as part of a bridging loan agreement and an agreement on free shares dated May 22, 2020: Date 21.10.2020 / Price 0.1746 EUR / Volume 211,425.00 EUR
Wade Menpes-Smith (Chairman)
Gift: Date 19.03.2020 / Price 0.00 EUR / Volume 0.00 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 21.10.2020 / Price 1.07 EUR / Volume 10,170.00 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 21.10.2020 / Price 1.09 EUR / Volume 1,090.00 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 21.10.2020 / Price 1.05 EUR / Volume 9,439.52 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 21.09.2020 / Price 1.13 EUR / Volume 3,400.00 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 21.09.2020 / Price 1.12 EUR / Volume 1.450.4 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 21.09.2020 / Price 1.08 EUR / Volume 2,493.00 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 04.02.2020 / Price 4.06 EUR / Volume 4,059.28 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 04.02.2020 / Price 4.00 EUR / Volume 800 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 20.11.2018 / Price 20.625 EUR / Volume 206.25 EUR
Wade Menpes-Smith (Chairman)
Purchase: Date 02.11.2018 / Price 20.625 EUR / Volume 4,743.75 EUR